A high-stakes power struggle has emerged within the National Institutes of Health (NIH), the US government's top biomedical research agency, as the Trump administration seeks to exert greater control over its leadership and operations.
The NIH is unique among federal agencies in that many of its directorships are not directly appointed by the White House or Congress. Instead, they are filled through a non-partisan process involving internal searches and external nominations from the scientific community. This has allowed the agency to maintain a degree of independence and avoid direct political interference.
However, under President Trump, there have been significant changes to this arrangement. The NIH director has been replaced by Jay Bhattacharya, a prominent critic of the agency's spending and priorities. Several other high-ranking officials have also departed or been placed on leave, including Lawrence Tabak, who served as principal deputy director for over a decade.
Bhattacharya has announced plans to appoint new leaders to many of the NIH's institutes and centers, which are responsible for overseeing billions of dollars in research funding. This move has raised concerns among some scientists and experts that the agency is becoming increasingly politicized.
The Trump administration has also taken steps to increase the number of political appointees at the NIH, including Seana Cranston, a former Republican Congressional staffer who serves as chief of staff to the NIH Director. This shift towards more partisan leadership has led to speculation that the agency is being used as a tool for advancing the president's agenda.
Despite these changes, some experts argue that the NIH's traditional non-partisan approach to hiring and promoting leaders has been effective in maintaining its scientific integrity and avoiding politicization. Mark Histed, an NIH scientist who has spoken out against Trump's approach to the agency, notes that having external scientists on search committees helps prevent politicization.
However, others warn that this approach is being undermined by the Trump administration's efforts to exert greater control over the agency. Diana DeGette, a Democratic representative from Colorado, has introduced legislation aimed at protecting the NIH from political interference and ensuring that the agency continues to prioritize scientific integrity.
As the NIH navigates these changing dynamics, one thing is clear: the agency's future direction will depend on how it balances its commitment to scientific research with the demands of a politicized administration. Will the agency be able to maintain its independence and continue to advance our understanding of human health and disease, or will it become just another tool for advancing partisan agendas? Only time will tell.
The NIH is unique among federal agencies in that many of its directorships are not directly appointed by the White House or Congress. Instead, they are filled through a non-partisan process involving internal searches and external nominations from the scientific community. This has allowed the agency to maintain a degree of independence and avoid direct political interference.
However, under President Trump, there have been significant changes to this arrangement. The NIH director has been replaced by Jay Bhattacharya, a prominent critic of the agency's spending and priorities. Several other high-ranking officials have also departed or been placed on leave, including Lawrence Tabak, who served as principal deputy director for over a decade.
Bhattacharya has announced plans to appoint new leaders to many of the NIH's institutes and centers, which are responsible for overseeing billions of dollars in research funding. This move has raised concerns among some scientists and experts that the agency is becoming increasingly politicized.
The Trump administration has also taken steps to increase the number of political appointees at the NIH, including Seana Cranston, a former Republican Congressional staffer who serves as chief of staff to the NIH Director. This shift towards more partisan leadership has led to speculation that the agency is being used as a tool for advancing the president's agenda.
Despite these changes, some experts argue that the NIH's traditional non-partisan approach to hiring and promoting leaders has been effective in maintaining its scientific integrity and avoiding politicization. Mark Histed, an NIH scientist who has spoken out against Trump's approach to the agency, notes that having external scientists on search committees helps prevent politicization.
However, others warn that this approach is being undermined by the Trump administration's efforts to exert greater control over the agency. Diana DeGette, a Democratic representative from Colorado, has introduced legislation aimed at protecting the NIH from political interference and ensuring that the agency continues to prioritize scientific integrity.
As the NIH navigates these changing dynamics, one thing is clear: the agency's future direction will depend on how it balances its commitment to scientific research with the demands of a politicized administration. Will the agency be able to maintain its independence and continue to advance our understanding of human health and disease, or will it become just another tool for advancing partisan agendas? Only time will tell.